Skip to main content
. 2022 Jan 10;27(2):434. doi: 10.3390/molecules27020434

Table 1.

PCSK9 inhibitors and their mechanism of action.

Mechanism of Action Examples
Blocking of PCSK9/LDLR complex formation Peptides
Adnectins
Monoclonal antibodies
(alirocumab, evolocumab, bocozicumab)
Suppression of PCSK9 expression CRISPR/Cas9 technology
Small molecules:
berberine, oleanolic acid
Antisense nucleotides
siRNA
Interference with PCSK9 secretion Sortilin
Sec24a